Pioneers in cannabinoid animal health

CannPal was founded by a team of experienced executives to establish a new standard of care in Animal Health by providing veterinarians with regulatory approved, Cannabinoid-based pharmaceuticals. We’ve identified an opportunity to develop first-in-class medicines for cats, dogs and horses, derived from the Cannabis plant, that have already shown safety and efficacy in humans and rodent studies.


To develop cost effective, first-in-class animal pharmaceuticals to provide acute solutions for your companions using medicinal cannabis, without the associated side effects.


We are committed to being the market leading research-intensive biopharmaceutical cannabis company dedicated to providing leading innovations and solutions for the animal health industry.


A highly credentialed Board of Directors and Management Team to lead the Company
Layton Mills
Founder & Managing Director
Layton is a seasoned executive with a passion for innovation and building brand assets. He is an FMCG entrepreneur with over 9 years of experience in brand and product development across a number of sectors with a heavy focus on consumer goods.
Geoff Starr
Geoff brings 32 years of executive experience to the company, 15 years of which were at Managing Director or CEO level, gained all around the world, but especially in Asia, Europe and Australia/NZ with Companies including MARS Global, Unilever and George Weston Foods.
Baden Bowen
Chief Financial Officer
Baden is a Chartered Accountant with more than 30 years of experience in administration and financial management within the accounting profession and commerce. His areas of specialty include company secretarial, financial accounting and management reporting for publicly and privately held Companies.
Rob Clifford
Non-Executive Director
Rob is an experienced change agent through Brand implementation and Business Strategy and Planning. His senior leadership roles have been in large multinational private and public corporations in Australia, China and Ireland.
Max Johnston
Non-Executive Director
Max has over 45 years of experience holding board positions across ASX listed companies and has senior executive experience in market leading corporate companies such as Unilever, United Distillers and Johnson & Johnson Pacific where he acted as Managing Director.
Dr Kate Adams
Non-Executive Director
Dr Kate Adams has held a number of government advisory and analyst roles in her career along with private company experience as the Director of Science, Technology and Intellectual Property at Palladion Partners. Kate is also a practicing Veterinarian and part owner of Bondi Veterinary Hospital.


A team of Advisers in Cannabinoid Formulation, Cannabis Regulations and Veterinary Science
Mara Gordon
Medical Cannabis Adviser
Mara is a Cannabinoid expert and founder of Aunt Zelda's, Calla Spring Wellness, and Zelda Therapeutics. Mara specializes in the development of treatment protocols utilizing Bio Pharmaceutical grade cannabis extracts for seriously ill patients in California, where she currently resides.
Dr Ted Whittem
Commercial Veterinary Adviser
Dr Ted Whittem is the current Head of the Melbourne Veterinary School, and a highly experienced Veterinary Pharmacologist. Dr Whittem has also worked as a senior executive in veterinary pharmaceuticals where he brought more than 30 products to the market.
Dr Rayson Tan
Chief Scientific Officer
Rayson is a passionate and experienced veterinarian and scientist who currently serves as the regulatory and research ethics executive for one of Australia's most prominent medical research institutes with a focus on biomedical and veterinary science.
Amanda Reiman
Cannabis Regulatory Adviser
Amanda Reiman was the Manager of Marijuana Law and Policy at the Drug Policy Alliance in California, where she worked to develop DPA’s marijuana reform work relating to litigation, legislative drafting, campaign strategy and policy advocacy in state, federal, and international jurisdictions.

Want more information ? Get in touch with us here.